These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7373370)

  • 1. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
    Alvarez Garijo JA; Vilches JJ; Aznar JA
    J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 5. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
    Fodstad H
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
    [No Abstract]   [Full Text] [Related]  

  • 6. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
    Fodstad H; Pilbrant A; Schannong M; Strömberg S
    Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H; Nilsson IM
    Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective trial of treating aneurysmal meningeal hemorrhage by delayed operation under cover of antifibrinolytic therapy].
    Irthum B; Chazal J; Commun C; Chabannes J; Janny P
    Neurochirurgie; 1986; 32(2):122-8. PubMed ID: 3523271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
    Maurice-Williams RS; Gordon YB; Sykes A
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
    Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
    Maurice-Williams RS
    Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature.
    Yamaura A; Nakamura T; Makino H; Hagihara Y
    Eur Neurol; 1980; 19(2):77-84. PubMed ID: 6893025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous thrombosis of ruptured intracranial aneurysm during treatment with tranexanic acid. Case report.
    Tanghetti B; Capra R; Marini G
    J Neurosurg Sci; 1985; 29(2):105-8. PubMed ID: 4093796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
    Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytic agents for ruptured intracranial aneurysms.
    Van Rossum J; Wintzen AR
    Br Med J; 1978 Aug; 2(6136):568. PubMed ID: 359088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.